Genetic testing may benefit patients with depression

A new U.S. Department of Veterans Affairs study found that pharmacogenomic testing can help providers avoid prescribing antidepressant medications that may have undesirable outcomes. Pharmacogenomics is the study of how genes ...


Fetal exposure to drugs may affect infants' brain development

A new study demonstrates that in utero exposure to mother's antiepileptic or antidepressant medication may affect development of the newborn brain networks. In the study, novel mathematical methods were developed to allow ...


Staying on long-term antidepressants reduces risk of relapse

When people stop taking antidepressants after a long period of use, just over half (56%) experience a relapse within a year, compared to 39% of those who stay on medication, finds a new study led by UCL researchers.

page 1 from 12